← Leaderboards
Hideo Watanabe
Icahn School Of Medicine At Mount Sinai
$3,228,772
Attributed
$3,579,541
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $701.5K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,579,541 · 2
By mechanism
R01$3,579,541 · 2
Top collaborators
- Eric Lee Snyder1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Miriam Merad$28,468,631
- Brian D Brown$18,622,393
- Juan P Wisnivesky$34,328,417
- Darrell J Irvine$37,519,809
- Chung Yin Kong$10,200,842
Others in their field
Other Emerging Leaders on “Cancer Diagnostics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$295,500,773
- Lynn Briscoe · Leidos Biomedical Research, Inc.$100,239,656
- Leonard Freedmand · Leidos Biomedical Research, Inc.$65,291,934
- Jean Macdonald · Dana-Farber Cancer Inst$26,990,229
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,466,796
- John Freymann · Leidos Biomedical Research, Inc.$14,011,208
Research focus
Cancer DiagnosticsBiologicalEnhancersTumorHeterogeneityMalignant NeoplasmsMalignant Neoplasm Of LungSignaling MoleculePatient-Focused OutcomesSpecimenGenomicsNormal CellSamplingCellsLung AdenocarcinomaMortalityChromatin StructureCancer PatientLead CandidateCessation Of LifeCancer EtiologyClassificationLungMouse Model
Grant awards (10)
Lineage evolution of a small cell lung cancer epigenomic subtype signified by NKX2-1$701,538
R01 · FY2025 · CA · contact PI
Lineage heterogeneity and plasticity in lung cancer$488,292
R01 · FY2023 · CA · contact PI
Lineage heterogeneity and plasticity in lung cancer$73,089
R01 · FY2023 · CA · contact PI
Lineage heterogeneity and plasticity in lung cancer$498,257
R01 · FY2022 · CA · contact PI
Lineage heterogeneity and plasticity in lung cancer$131,741
R01 · FY2022 · CA · contact PI
Lineage heterogeneity and plasticity in lung cancer$502,376
R01 · FY2021 · CA · contact PI
Lineage heterogeneity and plasticity in lung cancer$130,534
R01 · FY2021 · CA · contact PI
Lineage heterogeneity and plasticity in lung cancer$65,620
R01 · FY2021 · CA · contact PI
Lineage heterogeneity and plasticity in lung cancer$495,420
R01 · FY2020 · CA · contact PI
Lineage heterogeneity and plasticity in lung cancer$492,674
R01 · FY2019 · CA · contact PI